Search Results 221-230 of 18143 for CLL

  1. Oncology (Medical) - Clinical trials

    ... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...

  2. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...

  3. Doctors and departments - Mayo Clinic

    Chronic lymphocytic leukemia. Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with ...

  4. Ricardo D. Parrondo, M.D. - Doctors and Medical Staff - Mayo Clinic

    Parrondo, M.D., is a hematologist-oncologist, with a specialty interest in plasma cell dyscrasias and chronic lymphocytic leukemia. His clinical and ...

  5. Clinical trials - Oncology (Medical)

    ... Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL). Jacksonville, Fla. The purpose of this study is to assess the safety and tolerability ...

  6. Publications - Rebecca L. King, M.D. - Mayo Clinic

    Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter? Blood ...

  7. Lisocabtagene maraleucel (intravenous route) - Side effects & uses - Mayo Clinic

    Lisocabtagene maraleucel injection is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in patients who have ...

  8. Kay L. Medina, Ph.D. - Mayo Clinic Faculty Profiles

    ... chronic lymphocytic leukemia (CLL). Dr. Medina's lab recently showed that patients with CLL have impaired bone marrow hematopoiesis and significant ...

  9. Diane F. Jelinek, Ph.D. - Mayo Clinic Faculty Profiles

    Focus areas · Normal B cell and plasma cell biology. Dr. · Chronic lymphocytic leukemia (CLL). CLL is the most common adult-onset B cell cancer. · Multiple myeloma ...

  10. Cancer Clinical Trials - Medical Professionals

    ... chronic lymphocytic leukemia (CLL) risk across African Americans, Hispanics, and Caucasian populations. A Study to Evaluate Olaparib and Temozolomide in ...